Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
CHEK-ATP186 | Human | HEK293/Human PTK7 Stable Cell Line | |||
PT7-M5256 | Mouse | Mouse PTK7 / CCK4 Protein, Fc Tag (MALS verified) |
|
||
PT7-H82F5 | Human | Biotinylated Human PTK7 / CCK4 protein, Fc,Avitag™ (MALS verified) |
|
||
PT7-R52H6 | Rat | Rat PTK7 / CCK4 Protein, His Tag (MALS verified) |
|
||
PT7-R5255 | Rat | Rat PTK7 / CCK4 Protein, Fc Tag |
|
||
PT7-C52H3 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque PTK7 / CCK4 Protein, His Tag (MALS verified) |
|
||
PT7-R52H4 | Rabbit | Rabbit PTK7 / CCK4 Protein, His Tag (MALS verified) |
|
||
PT7-M52H3 | Mouse | Mouse PTK7 / CCK4 Protein, His Tag (MALS verified) |
|
||
PT7-H5253 | Human | Human PTK7 / CCK4 Protein, Fc Tag (MALS verified) |
|
||
PT7-H82E5 | Human | Biotinylated Human PTK7 / CCK4 protein, His,Avitag™ (MALS verified) |
|
||
PT7-H52H3 | Human | Human PTK7 / CCK4 Protein, His Tag (MALS verified) |
|
Expression analysis of human PTK7 on HEK293/Human PTK7 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human PTK7 Stable Cell Line or negative control cell using anti-human PTK7 antibody followed by fixation with 4% paraformaldehyde, and then stained with PE anti-human IgG Fc antibody.
Immobilized Cynomolgus / Rhesus macaque PTK7, His Tag (Cat. No. PT7-C52H3) at 1 μg/mL (100 μL/well) can bind Cofetuzumab Pelidotin with a linear range of 0.06-2 ng/mL (Routinely tested).
The purity of Mouse PTK7 Protein, Fc Tag (Cat. No. PT7-M5256) is more than 90% and the molecular weight of this protein is around 240-270 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
PRO-1107 | PRO-1107 | Phase 2 Clinical | ProfoundBio (Suzhou) Co Ltd | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Cofetuzumab Pelidotin | PF-06647020; PF-6647020; PTK7-ADC; PF-06523435; PF-7020; hu-24; ABBV-647; Anti-PTK7 ADC; h6M24-vc0101 | Phase 1 Clinical | Abbvie Inc, Stemcentrx Inc | Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
PRO-1107 | PRO-1107 | Phase 2 Clinical | ProfoundBio (Suzhou) Co Ltd | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Cofetuzumab Pelidotin | PF-06647020; PF-6647020; PTK7-ADC; PF-06523435; PF-7020; hu-24; ABBV-647; Anti-PTK7 ADC; h6M24-vc0101 | Phase 1 Clinical | Abbvie Inc, Stemcentrx Inc | Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.